Alexion Pharmaceuticals I...

NASDAQ: ALXN · Real-Time Price · USD
182.50
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Alexion Pharmaceuticals Revenue

Alexion Pharmaceuticals reported an annual revenue of $6.07B, reflecting a 21.61% growth. For the quarter ending March 31, 2021, Alexion Pharmaceuticals generated $1.64B in revenue.
Revenue (ttm)
6.07B
Revenue Growth
21.61%
Price / Sales Ratio
5.64
Revenue / Employee
1.58M
Employees
3,837
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2020 6.07B +21.61%
Dec 31, 2019 4.99B +20.81%
Dec 31, 2018 4.13B +16.34%
Dec 31, 2017 3.55B +15.15%
Dec 31, 2016 3.08B +18.43%
Dec 31, 2015 2.6B +16.58%
Dec 31, 2014 2.23B +43.99%
Dec 31, 2013 1.55B +36.79%
Dec 31, 2012 1.13B +44.76%
Dec 31, 2011 783.43M +44.82%
Dec 31, 2010 540.96M +39.85%
Dec 31, 2009 386.8M +49.29%
Dec 31, 2008 259.1M +259.65%
Dec 31, 2007 72.04M +4523.94%
Dec 31, 2006 1.56M -66.20%
Jul 31, 2004 4.61M +425.54%
Jul 31, 2003 877K -86.58%
Jul 31, 2002 6.54M -44.63%
Jul 31, 2001 11.8M -44.94%
Jul 31, 2000 21.44M +14.05%
Jul 31, 1999 18.8M +276.00%
Jul 31, 1998 5M +31.58%
Jul 31, 1997 3.8M +46.15%
Jul 31, 1996 2.6M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.